Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Kamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18

Showing 18 citing articles:

M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 9
Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22
Yanyan Zhang, Yun Huang, Dianping Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4312-4328
Open Access | Times Cited: 5
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
Vanessa Cristaldi, Lodovico Terzi di Bergamo, Lucrezia Patruno, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Role of the tumor microenvironment in CLL pathogenesis
Alexander F. vom Stein, Michael Hallek, Phuong‐Hien Nguyen
Seminars in Hematology (2023) Vol. 61, Iss. 3, pp. 142-154
Open Access | Times Cited: 10
A phase II study of zandelisib in patients with relapsed or refractory indolent non‐Hodgkin lymphoma: ME‐401‐K02 study
Wataru Munakata, Takahiro Kumode, Hideki Goto, et al.
British Journal of Haematology (2025)
Open Access
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment
Ali Golestan, Mohammadrasul Zareinejad, Amin Ramezani
Biomarkers in Medicine (2025), pp. 1-16
Closed Access
Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma
Zheng Yijia, Xiaoyu Li, Li‐Na Ma, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy
Haoran Sun, Zhong Cao, Binyu Zhao, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Induction of Regulatory T Cells After Virus Infection and Vaccination
Mansoureh Karimi Kakh, Mehrnoosh Doroudchi, AtefeGhamar Talepoor
Immunology (2025)
Closed Access
LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review
Shayan Khalilollah, Sina Kalantari Soltanieh, Raed Obaid Saleh, et al.
Cytokine (2024) Vol. 179, pp. 156585-156585
Closed Access | Times Cited: 3
Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development
William C. Theune, Chen Ju, Eileen Victoria Theune, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms
Sara Fraticelli, Marco Lucioni, Giuseppe Neri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7813-7813
Open Access | Times Cited: 5
Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment
Chunlan Zhang, Leiming Wang, Caigang Xu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer
Ze-Xuan Fang, Yan-Yu Hou, Zheng Wu, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 8, pp. 297-310
Open Access | Times Cited: 4
The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives
Ernesto Gargiulo, Mirta Giordano, Carsten Utoft Niemann, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia
Zlatko Roškar, Mojca Dreisinger, Primož Tič, et al.
Biosensors (2023) Vol. 13, Iss. 5, pp. 539-539
Open Access | Times Cited: 2
OSU-T315 overcomes immunosuppression in triple-negative breast cancer by targeting the ILK/NF-κB signaling pathway to enhance immunotherapeutic efficacy
Yi Wang, Yuenong Qin, Chunyu Wu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113530-113530
Open Access
Clinicopathological role of Cyclin A2 in uterine corpus endometrial carcinoma: Integration of tissue microarrays and ScRNA-Seq
Wei‐Jia Mo, Zi-Qian Liang, Jie-Zhuang Huang, et al.
The International Journal of Biological Markers (2024) Vol. 39, Iss. 2, pp. 168-183
Open Access
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
Vanessa Cristaldi, Lodovico Terzi di Bergamo, Lucrezia Patruno, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Interleukin‐6 transcripts up‐regulation in lymph nodes from unicentric and multicentric Castleman disease
Marco Lucioni, Gaia Morello, Caterina Cristinelli, et al.
eJHaem (2024) Vol. 5, Iss. 6, pp. 1182-1189
Open Access
Page 1

Scroll to top